Rifaximin Is Largely Safe and Well Tolerated but Caution Is Necessary When Taken With Statins-Reference-Cited by-同舟云学术

Rifaximin Is Largely Safe and Well Tolerated but Caution Is Necessary When Taken With Statins

Published:2014-10 Issue:10 Volume:12 Page:1765
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Cacciottolo Tessa M.,Kingdon Arjun,Alexander Graeme J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference5 articles.

1. Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy

2. Salix Parmaceuticals Inc. Xifaxan (rifaximin) tablets, 550 mg NDA 22-554: briefing document for the Gastrointestinal Drugs Advisory Committee Meeting, February 23, 2010.

3. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

4. Mitochondrial oxidative stress and permeability transition in Isoniazid and Rifampicin induced liver injury in mice

5. Mechanisms of Statin-Induced Myopathy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When Medications Backfire: A Case Report of Rifaximin-Induced Rhabdomyolysis in a Kidney Transplant Patient;Cureus;2024-06-18

2. The Use of Rifaximin in Patients With Cirrhosis;Hepatology;2021-06-07

3. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial;The Lancet Gastroenterology & Hepatology;2020-01

4. Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“;Zeitschrift für Gastroenterologie;2019-05

5. Rifaximin as a rare cause of rhabdomyolysis in cirrhosis;Clinical Case Reports;2018-05-27